NCT03028311 - Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 9, 2017

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Metastatic Liver CarcinomaStage IV Liver CancerStage IVA Liver CancerStage IVB Liver Cancer

Interventions

PROCEDURE

Angiography

Undergo angiography

PROCEDURE

Computed Tomography

Undergo SPECT-CT

PROCEDURE

Planar Imaging

Undergo planar imaging

RADIATION

Radioembolization

Undergo radioembolization

PROCEDURE

Single Photon Emission Computed Tomography

Undergo SPECT-CT

RADIATION

Technetium Tc-99m Albumin Aggregated

Given via arterial catheter

OTHER

Yttrium Y 90 Resin Microspheres

Given via arterial catheter

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER